We found anti-nuclear antibodies (ANA) in 26.7% of 150 relapsing-remitting and in 30.4% of 23 chronic progressive definite multiple sclerosis (MS) patients bv retromective chart review. These Datients did not have systemic hpus emhemato. Since ANA are not pathogenically relevant in MS, they are false-positive, and likely reflect systemic immune dys-regulation in MS.
ASJC Scopus subject areas
- Clinical Neurology